Basic Product Monograph Information for Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

Basic Product Monograph Information for Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) This guidance is intended to harmonize and to update the prescribing information for nonsteroidal anti-inflammatory drugs () indicated for controlling pain and inflammation associated with rheumatic diseases and other less severe conditions. Each Product Monograph is expected to contain objective, adequate and concise information on properties common to the active component and specific to the drug product. It should provide guidance on the safe and effective use of the drug, not only to the practitioner but also to the patient. 2021-07-07 Health Canada open-ouvert@tbs-sct.gc.ca Health and SafetyBasic product mMonograph informationnon-steroidal anti-inflammatory drugsNSAIDscontrolling pain and inflammationrheumatic diseasesproduct monograph contains objectiveadequate and concise information on drug productsafe and effective use of the drug Basic Product Monograph Information for Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)HTML https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/nonsteroidal-anti-inflammatory-drugs-nsaids/guidance-document-basic-product-monograph-information-nonsteroidal-anti-inflammatory-drugs-nsaids.html#intro Basic Product Monograph Information for Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)HTML https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/demandes-presentations/lignes-directrices/anti-inflammatoires-non-steroidiens-ains/ligne-directrice-information-base-monographie-anti-inflammatoires-non-steroidiens-ains.html#intro

This guidance is intended to harmonize and to update the prescribing information for nonsteroidal anti-inflammatory drugs () indicated for controlling pain and inflammation associated with rheumatic diseases and other less severe conditions. Each Product Monograph is expected to contain objective, adequate and concise information on properties common to the active component and specific to the drug product. It should provide guidance on the safe and effective use of the drug, not only to the practitioner but also to the patient.

Data and Resources

Similar records